A single nucleotide polymorphism in the MDM2 gene: from a molecular and cellular explanation to clinical effect.
about
Impact of MDM2 309T>G polymorphism on sarcomagenesisMDM2 promotor polymorphism and disease characteristics in chronic lymphocytic leukemia: results of an individual patient data-based meta-analysisInfluence of the MDM2 single nucleotide polymorphism SNP309 on tumour development in BRCA1 mutation carriers.Mutation analysis of the MDM4 gene in German breast cancer patientsAn information-theoretic analysis of genetics, gender and age in cancer patientsPrediction by graph theoretic measures of structural effects in proteins arising from non-synonymous single nucleotide polymorphisms.BayesPI - a new model to study protein-DNA interactions: a case study of condition-specific protein binding parameters for Yeast transcription factorsEffect of MDM2 SNP309 and p53 codon 72 polymorphisms on lung cancer risk and survival among non-smoking Chinese women in SingaporeAssociation between polymorphisms in TP53 and MDM2 genes and susceptibility to prostate cancerp53 Arg72Pro, MDM2 T309G and CCND1 G870A polymorphisms are not associated with susceptibility to esophageal adenocarcinomaSingle-nucleotide polymorphism (c.309T>G) in the MDM2 gene and lung cancer riskThe Mdm2-p53 relationship evolves: Mdm2 swings both ways as an oncogene and a tumor suppressor.Correlating CpG islands, motifs, and sequence variants in human chromosome 21.A 40-bp insertion/deletion polymorphism of Murine Double Minute2 (MDM2) increased the risk of breast cancer in Zahedan, Southeast Iran.The MDM2 309T>G polymorphism and ovarian cancer risk: a meta-analysis of 1534 cases and 2211 controls.MDM2 SNP309 rs2279744 polymorphism and gastric cancer risk: a meta-analysis.Rapid detection of SNP (c.309T>G) in the MDM2 gene by the Duplex SmartAmp method.p53 Arg72Pro and MDM2 T309G polymorphisms, histology, and esophageal cancer prognosisFuse binding protein antagonizes the transcription activity of tumor suppressor protein p53.The T309G MDM2 gene polymorphism is a novel risk factor for proliferative vitreoretinopathy.TP53 and MDM2 gene polymorphisms, gene-gene interaction, and hepatocellular carcinoma risk: evidence from an updated meta-analysis.Evidence for an epistatic effect between TP53 R72P and MDM2 T309G SNPs in HIV infection: a cross-sectional study in women from South Brazil.TP53 and MDM2 gene polymorphisms and risk of hepatocellular carcinoma among Italian patients.Association between polymorphisms in tumor suppressor genes and oncogenes and risk of hepatocellular carcinoma: a case-control study in an HCC epidemic area within the Han Chinese population.Mouse double minute-2 homolog (MDM2)-rs2279744 polymorphism associated with lung cancer risk in a Northeastern Chinese population.SNP55, a new functional polymorphism of MDM2-P2 promoter, contributes to allele-specific expression of MDM2 in endometrial cancers.Towards an understanding of the role of p53 in adrenocortical carcinogenesis.Low Prevalence of TP53 Mutations and MDM2 Amplifications in Pediatric RhabdomyosarcomaHaploinsufficiency of Mdm2 and Mdm4 in tumorigenesis and developmentIdentification of functional DNA variants in the constitutive promoter region of MDM2p53 and disease: when the guardian angel fails.Exploiting the p53 pathway for the diagnosis and therapy of human cancer.A single nucleotide polymorphism in the p53 pathway interacts with gender, environmental stresses and tumor genetics to influence cancer in humans.Early gene expression of acute myeloid leukemia in response to chemotherapy.Excessive genomic DNA copy number variation in the Li-Fraumeni cancer predisposition syndrome.Prognostic potential of the MDM2 309T>G polymorphism in stage I lung adenocarcinoma.A role for biomarkers in the screening and diagnosis of breast cancer in younger women.Association of MDM2 promoter T309G polymorphism with oral cancer risk: A meta-analysis of 3,536 subjectsToward a genetics of cancer resistance.The risks, degree of malignancy and clinical progression of prostate cancer associated with the MDM2 T309G polymorphism: a meta-analysis
P2860
Q28608667-59ABC1A8-C56F-4BC8-B33A-BF14B693BE34Q30840070-2665194A-4210-40B4-A9F2-B3B115D226FCQ33237559-0877C4F8-EFD9-4BE4-9E23-1ECB3E7195C6Q33320072-153F2AD3-C62A-48DB-A139-E639427C6874Q33327370-EEBDE1E3-4A91-4B0D-BFCD-CE7125A6235CQ33354935-90187157-B5FD-49D9-AE9F-61A17AF64EBBQ33512623-E2C00248-BBA8-4DBB-89E1-34C132543C21Q33539409-F5368250-DA29-4063-AE7A-FA9991836546Q33597618-DA586A50-9B25-4B5B-BD11-B6D6D747E38AQ33835838-C3951B88-4351-4B26-BF15-37C0AD29DEC2Q33932445-8901887A-66B7-473D-99AE-256BBCACCA36Q34030117-EC787D94-D7D4-4809-AB1B-319030688166Q34046438-8C4C5F39-8A58-4904-A5CE-C96D93BC7316Q34475865-7D933AD9-024B-478A-AE15-EAEBB86091EBQ34575963-AC4E7458-54D0-40A6-9FB7-E728B89520BFQ34602737-A64DE1D3-6CBA-45CD-88A8-E3DB252951C5Q34658158-DAD6045C-54A4-42B3-BC0F-E9525D963767Q34848523-196DF893-B084-4D84-9B57-3F2451512548Q34968621-5083861E-3AEF-496C-A018-723AC73C3B3DQ35070151-86AE5E42-E949-47C2-B0AA-0695CE852B13Q35077721-4836FCC3-7B1D-4FA4-A863-543A5C95B04BQ35107447-A9EBA524-E001-4C87-B21A-F0845A73F44CQ35206102-1F2FD451-27C6-4A47-81DC-2F7ECE648E83Q35440600-CD2B55F2-FE09-43B6-9A0A-C84EE377218FQ35663480-2E81DEB1-10F2-4659-938E-9CBEC57B55D9Q35751762-8895BE4A-56A6-43F9-8D3B-CC7AFDDB1B08Q35783751-2D54A04A-489F-4880-ABEE-51A19B904C50Q35897781-2F398DC2-E5B0-412F-9D0D-85B330616916Q35950132-14E9BE5B-C761-47DE-B3F3-8ADF7F168DF0Q36405382-A517C0B7-8338-433B-BD6C-F097A43FCA69Q36430165-ED0869F1-22C0-43A9-AF7E-F94F591D9165Q36547790-72D6990E-168F-436C-B8DA-159F8ACC990AQ36745377-767FA145-C991-40CC-ADBE-37B102010747Q36817144-981C5923-4AAB-4EA5-BACA-47D583778ECAQ36837569-BD59339B-6599-4423-9F25-A2217101AFA2Q36945832-99C57B55-4DE7-4ABF-8129-F951D0CDB5C9Q36950426-4EFCA224-FBDE-4A70-8FDE-2FC7B089B0E8Q37001861-FBD07566-9AC5-42B5-8A99-F79242395A12Q37070576-152FEDF7-ECCB-42A7-908F-6A7001B5C092Q37074138-7EB3158D-7CDA-421E-B591-379AE745E7D3
P2860
A single nucleotide polymorphism in the MDM2 gene: from a molecular and cellular explanation to clinical effect.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
A single nucleotide polymorphi ...... xplanation to clinical effect.
@ast
A single nucleotide polymorphi ...... xplanation to clinical effect.
@en
type
label
A single nucleotide polymorphi ...... xplanation to clinical effect.
@ast
A single nucleotide polymorphi ...... xplanation to clinical effect.
@en
prefLabel
A single nucleotide polymorphi ...... xplanation to clinical effect.
@ast
A single nucleotide polymorphi ...... xplanation to clinical effect.
@en
P1433
P1476
A single nucleotide polymorphi ...... xplanation to clinical effect.
@en
P2093
Gareth L Bond
P304
P356
10.1158/0008-5472.CAN-05-0825
P407
P577
2005-07-01T00:00:00Z